Nutritional Outlook

Nutritional Outlook, June 2018

Issue link:

Contents of this Issue


Page 64 of 69

NUTRITIONAL OUTLOOK ■ 59 JUNE 2018 3. Laslett LJ et al. "T e worldwide environment of cardiovascular disease: prevalence, diag- nosis, therapy, and policy issues: a report from the American College of Cardiology." Journal of the American College of Cardiol- ogy, vol. 60, suppl. 25 (December 25, 2012): S1-S49 4. T e Council for Responsible Nutrition. "2017 CRN Consumer Survey on Dietary Supplements" 5. T e Council for Responsible Nutrition. "2016 CRN Consumer Survey on Dietary Supplements" 6. T e Council for Responsible Nutrition. "2015 CRN Consumer Survey on Dietary Supplements" 7. Nishida Y et al. "Quenching activities of com- mon hydrophilic and lipophilic antioxidants against singlet oxygen using chemilumines- cence detection system." Carotenoid Science, vol. 11 (2007): 16-20 8. Algalif (2017). Company calculations. 9. Niyogi KK et al. "T e roles of specif c xantho- phylls in photoprotection." Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 25 (December 9, 1997): 14162-14167 10. Kattoor AJ et al. "Oxidative stress in atheroscle- rosis." Current Atherosclerosis Reports, vol. 19, no. 11 (September 18, 2017): 42 11. Grootaert MO et al. "Defective autophagy in vascular smooth muscle cells accelerates se- nescence and promotes neointima formation and atherogenesis." Autophagy, vo. 11, no. 11 (November 2, 2015): 2014–2032 12. Yang X et al. "Oxidative stress-mediated athero- sclerosis: mechanisms and therapies." Frontiers in Physiology. Published online August 23, 2017. 13. Kim YK et al. "T e ef ects of astaxanthin sup- plements on lipid peroxidation and antioxi- dant status in postmenopausal women." Nu- tritional Sciences, vol. 7, no. 1 ( January 1, 2004): 41-46 14. Choi HD et al. "Positive ef ects of astaxan- thin on lipid prof les and oxidative stress in overweight subjects." Plant Foods for Human Nutrition, vol. 66, no. 4 (November 2011): 363-369 15. Iwabayashi M et al. (2009). "Ef cacy and safety of eight-week treatment with astaxanthin in individuals screened for increased oxidative stress burden." Anti-Aging Medicine, vol. 6, no. 4 ( January 2009): 15-21 16. Chew W et al. "Astaxanthin decreases in- f ammatory biomarkers associated with cardiovascular disease in human umbilical vein endothelial cells." American Journal of Advanced Food Science and Technology, vol. 1 ( January 2013): 1-17 17. Yoshida H et al. "Administration of natural astaxanthin increases serum HDL-choles- terol and adiponectin in subjects with mild hyperlipidemia." Atherosclerosis, vol. 209, no. 2 (April 2010): 520-523 18. Saito M et al. "Astaxanthin increases choroi- dal blood f ow velocity." Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 2 (February 2012): 239-245 19. Miyawaki H et al. "Ef ects of astaxanthin on human blood rheology." Journal of Clini- cal Biochemistry and Nutrition, vol. 43, no. 2 (September 2008): 69-74 Tel: 317.895.9000 | Fax: 317.895.9340 | TABLETS | CAPSULES POWDERS | GRANULATION PACKAGING | BLISTER PACKS POUCHES RESEARCH & PRODUCT DEVELOPMENT CUSTOM FORMULATIONS REGISTERED FACILITY G o o d M a n u f a c t u r i n g P r a c t i c e GMP CERTIFIED GMP Registered

Articles in this issue

Links on this page

Archives of this issue

view archives of Nutritional Outlook - Nutritional Outlook, June 2018